MediFind
Condition

Hydatidiform Mole

Symptoms, Doctors, Treatments, Research & More

Active Clinical Trials

Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 26
  • Start Date: February 12, 2020
TROPHAMET, a Phase I/II Trial of Avelumab and METhotrexate in Low-risk Gestational TROPHoblastic Neoplasias as First Line Treatment
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 306
  • Start Date: December 24, 2018
Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule,A Prospective Multicentre Randomized Controlled Trial
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 29
  • Start Date: February 21, 2017
A Phase II Trial of Avelumab in Chemo-resistant Gestational Trophoblastic Neoplasias (GTN)
Clinical Trial
Biological
  • Status: Active, not recruiting
  • Study Type: Biological
  • Participants: 580
  • Start Date: July 2012
BioThrax® (Anthrax) Vaccine in Pregnancy Registry
Clinical Trial
Other
  • Status: Recruiting
  • Participants: 25500
  • Start Date: November 1999
The French National Reference Centre of Gestational Trophoblastic Disease
Clinical Trial
Other
  • Status: Recruiting
  • Participants: 100
  • Start Date: December 1998
Genetic Studies in Gestational Trophoblastic Disease